Setrusumab

Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer[1].

Product Specifications

CAS Number

[1847394-95-9]

Product Name Alternative

BPS 804

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/setrusumab.html

Purity

99.9

Solubility

10 mM in DMSO

Smiles

[Setrusumab]

Molecular Weight

(143.44 kDa)

References & Citations

[1]Hesse E, et al. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight. 2019 Apr 9;5 (9) :e125543.